Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
- Conditions
- Ovarian Neoplasms
- Registration Number
- NCT00551577
- Lead Sponsor
- University Hospital, Bonn
- Brief Summary
The purpose of this study is to evaluate response to neoadjuvant chemotherapy by imaging and observation of anatomical and biological indicators (i.e. ascites or continuous measurement of tumor marker CA 125). Furthermore the optimal number of preoperative administered cycles of combination chemotherapy with carboplatin and docetaxel should be determined.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 100
- histological confirmed ovarian neoplasm
- Figo stage IIIC (2cm extrapelvic disease) or Figo IV
- more than 500 ml ascites volume (measured by sonography)
- age > 18 years old
- ECOG <= 2
- adequate hepatological, renal and haematological function
- informed consent
- concomitant or previous malignant diseases
- debulking procedures on initial surgical approach
- existing peripheral sensoric neuropathy >= grade 2
- acute infections
- mental disorders, cerebral metastasis
- bowel obstruction
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Preoperative reduction of ascites volume preoperative: after 2nd or 3rd cycle of chemotherapy (3-weekly course)
- Secondary Outcome Measures
Name Time Method Evaluation of overall response, Evaluation of postoperative tumor size, Evaluation of perioperative morbidity and mortality, QOL 6 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
Department of Gynaecolgy and Obstetrics, University hopsital
🇩🇪Bonn, Germany
Department of Gynaecology, University hospital
🇩🇪Hamburg, Germany
Department of Gynaecolgy and Obstetrics, University hopsital🇩🇪Bonn, GermanyMartin Pölcher, MDSub Investigator
